Komiyama M, Wada H, Ura S, Yamakage H, Satoh-Asahara N, Shimatsu A, Koyama H, Kono K, Takahashi Y, Hasegawa K. Analysis of factors that determine weight gain during smoking cessation therapy. PLoS One. 8: e72010, 2013 (IF: 3.240, CI: 29) 査読付
Yamada-Goto N, Katsuura G, Ebihara K, Inuzuka M, Ochi Y, Yamashita Y, Kusakabe T, Yasoda A, Satoh-Asahara N, Ariyasu H, Hosoda K, Nakao K. Intracerebroventricular administration of C-type natriuretic peptide suppresses food intake via activation of the melanocortin system in mice. Diabetes. 62: 1500-1504, 2013 (IF: 9.461, CI: 26) 査読付
Usui T, Tochiya M, Sasaki Y, Muranaka K, Yamakage H, Himeno A, Shimatsu A, Inaguma A, Ueno T, Uchiyama S, Satoh-Asahara N. Effects of natural S-equol supplements on overweight or obesity and metabolic syndrome in the Japanese, based on sex and equol status. Clin Endocrinol (Oxf). 78: 365-372, 2013 (IF: 3.478, CI: 82) 査読付
Satoh-Asahara N (corresponding), Sasaki Y, Wada H, Tochiya M, Iguchi A, Nakagawachi R, Odori S, Kono S, Hasegawa K, Shimatsu A. A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients. Metabolism. 62: 347-351, 2013 (IF: 8.697, CI: 137) 査読付
Iguchi A, Yamakage H, Tochiya M, Muranaka K, Sasaki Y, Kono S, Shimatsu A, Satoh-Asahara N (corresponding). Effect of weight reduction therapy on obstructive sleep apnea syndrome and arterial stiffness in the patients with obesity and metabolic syndrome. J Atheroscler Thromb. 20: 807-820, 2013 (IF: 4.928, CI: 28) 査読付
Takanabe-Mori R, Ono K, Wada H, Takaya T, Ura S, Yamakage H, Satoh-Asahara N, Shimatsu A, Takahashi Y, Fujita M, Fujita Y, Sawamura T, Hasegawa K. Lectin-like oxidized low-density lipoprotein receptor-1 plays an important role in vascular inflammation of current smokers. J Atheroscler Thromb. 20: 585-590, 2013 (IF: 4.928, CI: 20) 査読付
Shirai K, Saiki A, Oikawa S, Teramoto T, Yamada N, Ishibashi S, Tada N, Miyazaki S, Inoue I, Murano S, Sakane N, Satoh-Asahara N, Bujo H, Miyashita Y, Saito Y. The effect of partial use of formula diet on weight reduction and metabolic variables in obese type 2 diabetic patients -multicenter trial. Obes Res Clin Pract. 7: e43-e54, 2013 (IF: 2.288, CI: 12) 査読付
Satoh-Asahara N (corresponding), Shimatsu A, Sasaki Y, Nakaoka H, Himeno A, Tochiya M, Kono S, Takaya T, Ono K, Wada H, Suganami T, Hasegawa K, Ogawa Y. Highly purified eicosapentaenoic acid increases interleukin-10 levels of peripheral blood monocytes in obese patients with dyslipidemia. Diabetes Care. 35: 2631-2639, 2012 (IF: 19.112, CI:52) 査読付
Himeno A, Satoh-Asahara N (corresponding), Usui T, Wada H, Tochiya M, Kono S, Yamada-Goto N, Katsuura G, Hasegawa K, Nakao K, Shimatsu A. Salivary cortisol levels are associated with outcomes of weight reduction therapy in obese Japanese patients. Metabolism. 61: 255-261, 2012 (IF: 8.697, CI: 10) 査読付
Wada H, Ura S, Satoh-Asahara N, Kitaoka S, Mashiba S, Akao M, Abe M, Ono K, Morimoto T, Fujita M, Shimatsu A, Takahashi Y, Hasegawa K. α1-Antitrypsin-low-density-lipoprotein serves as a marker of smoking-specific oxidative stress. J Atheroscler Thromb. 19: 47-58, 2012 (IF: 4.928, CI: 15) 査読付
Ichioka M, Suganami T, Tsuda N, Shirakawa I, Hirata Y, Satoh-Asahara N, Shimoda Y, Tanaka M, Kim-Saijo M, Miyamoto Y, Kamei Y, Sata M, Ogawa Y. Increased expression of macrophage-inducible C-type lectin in adipose tissue of obese mice and humans. Diabetes. 60: 819-826, 2011 (IF: 9.461, CI: 51) 査読付
Satoh-Asahara N (corresponding), Suganami T, Majima T, Kotani K, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Oishi M, Himeno A, Kono S, Sugawara A, Hattori M, Ogawa Y, Shimatsu A, The Japan Obesity Metabolic Syndrome Study (JOMS) Group. Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome. Clin J Am Soc Nephrol. 6: 265-273, 2011 (IF: 8.237, CI: 27) 査読付
Arai D, Yamaguchi S, Murakami M, Nakakuki T, Fukuda S, Satoh-Asahara N, Tsukahara T. Characteristics of carotid plaque findings on ultrasonography and black blood magnetic resonance imaging in comparison with pathological findings. Acta Neurochir Suppl. 112: 15-19, 2011 (IF: 2.216, CI: 10) 査読付
Shimada S, Hasegawa K, Wada H, Terashima S, Satoh-Asahara N, Yamakage H, Kitaoka S, Akao M, Shimatsu A, Takahashi Y. High blood viscosity is closely associated with cigarette smoking and markedly reduced by smoking cessation. Circ J. 75: 185-189, 2011 (IF: 2.993, CI: 41) 査読付
Kotani K, Satoh-Asahara N, Kato Y, Araki R, Himeno A, Yamakage H, Koyama K, Tanabe T, Oishi M, Okajima T, Shimatsu A, The Japan Obesity Metabolic Syndrome Study (JOMS) Group. Serum amyloid A low-density lipoprotein levels and smoking status in obese Japanese patients. J Int Med Res. 39: 1917-1922, 2011 (IF: 1.671, CI: 7) 査読付
Wada H, Ura S, Kitaoka S, Satoh-Asahara N, Horie T, Ono K, Takaya T, Takanabe-Mori R, Akao M, Abe M, Morimoto T, Murayama T, Yokode M, Fujita M, Shimatsu A, Hasegawa K. Distinct characteristics of circulating vascular endothelial growth factor-A and C levels in human subjects. PLoS One. 6: e29351, 2011 (IF: 3.240, CI: 43) 査読付
Kotani K, Satoh-Asahara N, Kato Y, Araki R, Himeno A, Yamakage H, Koyama K, Tanabe T, Oishi M, Okajima T, Shimatsu A, The Japan Obesity Metabolic Syndrome Study (JOMS) Group. Remnantt-like particle cholesterol and serum amyloid A-low-density lipoprotein levels in obese subjects with metabolic syndrome. J Clin Lipidol. 5: 395-400, 2011 (IF: 4.766, CI: 11) 査読付
Takanabe-Mori R, Ono K, Sowa N, Wada H, Takaya T, Horie T, Satoh-Asahara N, Shimatsu A, Fujita M, Sawamura T, Hasegawa K. LOX-1 is required for the adipose tissue expression of proinflammatory cytokines in high-fat diet-induced obese mice. Biochem Biophys Res Commun. 398: 576-580, 2010 (IF: 3.575, CI: 27) 査読付
Kotani K, Satoh N, Yamada T, Gugliucci A. The potential of serum amyloid A-LDL as a novel biomarker for cardiovascular disease risk. Clin Lipidol. 5: 489-495, 2010 (IF: 0.540, CI: 8) 査読付
Kotani K, Satoh N, Yamada K, Taniguchi N, Shimatsu A. The influence of metabolic syndrome and chronic kidney disease on the hemorheology assessed by the microchannel method. J Physiol Anthropol. 29: 157-160, 2010 (IF: 2.867, CI: 3) 査読付
Wada H, Satoh N, Kitaoka S, Ono K, Morimoto T, Kawamura T, Nakano, T, Fujita M, Kita T, Shimatsu A, Hasegawa K. Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance. Atherosclerosis. 208: 512-517, 2010 (IF: 5.162, CI: 27) 査読付
Wada H, Shinjo D, Kameda S, Ono K, Satoh N, Morimoto T, Osakada G, Nakano T, Fujita M, Shimatsu A, Hasegawa K. Transmitral E/A ratio decreases in association with abdominal fat accumulation in patients with impaired glucose tolerance or mild diabetes without left ventricular hypertrophy. Heart Vessels. 25: 45-50, 2010 (IF: 2.037, CI: 5) 査読付
Satoh N (corresponding), Shimatsu A, Kotani K, Himeno A, Majima T, Yamada K, Suganami T, Ogawa Y. Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decrease in serum amyloid A-LDL in metabolic syndrome. Hypertens Res. 32: 1004-1008, 2009 (IF: 3.872, CI: 67) 査読付
Kotani K, Satoh N, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Oishi M, Yamakage H, Yamada K, Hattori M, Shimatsu A, Japan Obesity and Metabolic Syndrome Study Group. A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndrome. Atherosclerosis. 204: 526-531, 2009 (IF: 5.162, CI: 34) 査読付
Satoh N (corresponding), Kotani K, Wada H, Himeno A, Shimada S, Sasaki Y, Yamada K, Shimatsu A, Hasegawa K. Unfavorable blood rheology is closely associated with arterial stiffness in obese patients. Endocr J. 56: 915-918, 2009 (IF: 2.349, CI: 16) 査読付
Majima T, Shimatsu A, Komatsu Y, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K. Effects of risedronate or alfacalcidol on bone mineral density, bone turnover, back pain, and fractures in Japanese men with primary osteoporosis: results of a two-year strict observational study. J Bone Miner Metab. 27: 168-174, 2009 (IF: 2.626, CI: 11) 査読付
Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y, Yoshioka T, Ogawa Y, Imamaki H, Kusakabe T, Ebihara K, Omata M, Satoh N, Sugawara A, Barasch J, Nakao K. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage in glomeruli, proximal and distal nephrons. Kidney Int. 75: 285-294, 2009 (IF: 10.612, CI: 207) 査読付
Kobayashi N, Masuzaki H, Chusho H, Fujimoto M, Ebihara K, Hirata M, Miyanaga F, Tanaka T, Tomita T, Kusakabe T, Yasue S, Ishii T, Tanioka H, Arai N, Miyawaki T, Aono H, Saito N, Satoh N, Nakajima M, Okabayashi Y, Miyata H, Matsuzaki K, Arai H, Hosoda K, Hayashi T, and Nakao K. Index of the systemic balance of end products of glucocorticoid metabolism in fresh urine from humans - Its potential usefulness in the evaluation of obesity-related diseases-. Obes Res Clin Pract. 3: 53-63, 2009 (IF: 2.288, CI: 0) 査読付
Takanabe R, Ono K, Abe Y, Takaya T, Horie T, Wada H, Kita T, Satoh N, Shimatsu A, Hasegawa K. Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet. Biochem Biophys Res Commun. 376: 728-732, 2008 (IF: 3.575, CI: 172) 査読付
Yamada H, Yoshida M, Nakano Y, Suganami T, Satoh N, Mita T, Azuma K, Itoh M, Yamamoto Y, Kamei Y, Horie M, Watada H, Ogawa Y. In vivo and In vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acid. Arterioscler Thromb Vasc Biol. 28: 2173-2179, 2008 (IF: 8.313, CI: 81) 査読付
Satoh N (corresponding), Shimatsu A, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Oishi M, Kotani K, Ogawa Y, for the Japan Obesity and Metabolic Syndrome Study (JOMS) Group. Evaluation of cardio-ankle vascular index, a new indicator of arterial stiffness independent of blood pressure, in obesity and metabolic syndrome. Hypertens Res. 31: 1921-1930, 2008 (IF: 3.872, CI: 104) 査読付
Wada H, Abe M, Ono K, Morimoto T, Kawamura T, Takaya T, Satoh N, Fujita M, Kita T, Shimatsu A, Hasegawa K. Statins activate GATA-6 and induce differentiated vascular smooth muscle cells. Biochem Biophys Res Commun. 374: 731-736, 2008 (IF: 3.575, CI: 6) 査読付
Satoh N (corresponding), Wada H, Ono K, Yamakage H, Yamada K, Nakano T, Hattori M, Shimatsu A, Kuzuya H, Hasegawa K. Small dense LDL-cholesterol relative to LDL-cholesterol is a strong independent determinant of hypoadiponectinemia in metabolic syndrome. Circ J. 72: 932-939, 2008 (IF: 2.993, CI: 20) 査読付
Majima T, Shimatsu A, Komatsu Y, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K. Efficacy of risedronate in Japanese male patients with primary osteoporosis. Intern Med. 47: 717-723, 2008 (IF: 1.271, CI: 6) 査読付
Majima T, Shimatsu A, Komatsu Y, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K. Increased bone turnover in patients with hypercholesterolemia. Endocr J. 55: 143-151, 2008 (IF: 2.349, CI: 26) 査読付
Majima T, Komatsu Y, Shimatsu A, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K. Efficacy of combined treatment with raloxifene and alfacalcidol on bone density and biochemical markers of bone turnover in postmenopausal osteoporosis. Endocr J. 55: 127-134, 2008 (IF: 2.349, CI: 8) 査読付
Majima T, Shimatsu A, Komatsu Y, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K. Association between baseline values of bone turnover markers and bone mineral density and their response to raloxifene treatment in Japanese postmenopausal women with osteoporosis. Endocr J. 55: 41-48, 2008 (IF: 2.349, CI: 7) 査読付
Majima T, Shimatsu A, Satoh N, Komatsu Y, Fukao A, Ninomiya K, Matsumura T, Nakao K. Three-month changes in bone turnover markers and bone mineral density response to raloxifene in Japanese postmenopausal women with osteoporosis. J Bone Miner Metab. 26: 178-184, 2008 (IF: 2.626, CI: 6) 査読付
Majima T, Shimatsu A, Komatsu Y, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K. Short-term effects of pitavastatin on biochemical markers of bone turnover in patients with hypercholesterolemia. Intern Med. 46: 1967-1973, 2007 (IF: 1.271, CI: 19) 査読付
Majima T, Komatsu Y, Shimatsu A, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K. Clinical significance of one-year treatment with raloxifene on bone and lipid metabolism in Japanese postmenopausal women with osteoporosis. Endocr J. 54: 855-862, 2007 (IF: 2.349, CI: 6) 査読付
Itoh M, Suganami T, Satoh N, Tanimoto-Koyama K, Yuan X, Tanaka M, Kawano H, Yano T, Aoe S, Takeya M, Shimatsu A, Kuzuya H, Kamei Y, Ogawa Y. Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol. 27: 1918-1925, 2007 (IF: 8.313, CI: 220) 査読付
Satoh N (corresponding), Shimatsu A, Kotani K, Sakane N, Yamada K, Suganami T, Kuzuya H, Ogawa Y. Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome. Diabetes Care. 30: 144-146, 2007 (IF: 19.112, CI: 108) 査読付
Satoh N, Shimatsu A, Yamada K, Aizawa-Abe M, Suganami T, Kuzuya H, Ogawa Y. An α-glucosidase inhibitor voglibose reduces oxidative stress markers and soluble intercellular adhesion molecule-1 in obese type 2 diabetes. Metabolism. 55: 786-793, 2006 (IF: 8.697, CI: 31) 査読付
Satoh N, Naruse M, Usui T, Tagami T, Suganami T, Yamada K, Kuzuya H, Shimatsu A, Ogawa Y. Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care. 27: 2488-2490, 2004 (IF: 19.112, CI: 174) 査読付
Tagami T, Satoh N, Usui T, Yamada K, Shimatsu A, Kuzuya H. Adiponectin in anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab. 89: 1833-1837, 2004 (IF: 5.958, CI: 96) 査読付
Hashimoto M, Tagami T, Shigemitsu M, Satoh N, Usui T, Yamada K, Shimatsu A, Kuzuya H, Sugawara A. Case of pseudo-hypoparathyroidism type II with Basedow’s disease. Clin Calcium. 14: 122-126, 2004 (IF: 未掲載, CI: 未掲載) 査読付
Satoh N, Ogawa Y, Usui T, Kono S, Uesugi H, Sugiyama H, Sugawara A, Yamada K, Shimatsu A, Kuzuya H, Nakao K. Antiatherogenic effect of pioglitazone in type 2 diabetic patients, irrespective of the responsiveness to its antidiabetic effect. Diabetes Care. 26: 2493-2499, 2003 (IF: 19.112, CI: 242) 査読付
Matsuoka Y, Furuyashiki T, Bito H, Ushikubi F, Tanaka Y, Kobayashi T, Muro S, Satoh N, Kayahara T, Higashi M, Mizoguchi A, Shichi H, Fukuda Y, Nakao K, Narumiya S. Impaired adrenocorticotropic hormone response to bacterial endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes. Proc Natl Acad Sci U.S.A. 100: 4132-4137, 2003 (IF: 11.205, CI: 88) 査読付
Matsuoka N, Ogawa Y, Masuzaki H, Ebihara K, Aizawa-Abe M, Satoh N, Ishikawa E, Fujisawa Y, Kosaki A, Yamada K, Kuzuya H, Nakao K. Decreased triglyceride-rich lipoproteins in transgenic skinny mice overexpressing leptin. Am J Physiol Endocrinol Metab. 280: E334-E339, 2001 (IF: 4.310, CI: 21) 査読付
Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, Matsuoka N, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Nakao K. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest. 105: 1243-1252, 2000 (IF: 14.808, CI: 381) 査読付
Ebihara K, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Satoh N, Tamaki M, Yoshioka T, Hayase M, Matsuoka N, Aizawa-Abe M, Yoshimasa Y, Nakao K. Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action. Diabetes. 48: 2028-2033, 1999 (IF: 9.461, CI: 143) 査読付
Ogawa Y, Masuzaki H, Hosoda K, Aizawa-Abe M, Suga J, Suda M, Ebihara K, Iwai H, Matsuoka N, Satoh N, Odaka H, Kasuga H, Fujisawa Y, Inoue G, Nishimura H, Yoshimasa Y, Nakao K. Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes. 48: 1822-1829, 1999 (IF: 9.461, CI: 165) 査読付
Satoh N, Ogawa Y, Katsuura G, Numata Y, Tsuji T, Hayase M, Ebihara K, Masuzaki H, Hosoda K, Yoshimasa Y, Nakao K. Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion. Diabetes. 48: 1787-1793, 1999 (IF: 9.461, CI: 172) 査読付【博士論文：京都大学 甲 第2110号】
Masuzaki H, Ogawa Y, Aizawa-Abe M, Hosoda K, Suga J, Ebihara K, Satoh N, Iwai H, Inoue G, Nishimura H, Yoshimasa Y, Nakao K. Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes. 48: 1615-1622, 1999 (IF: 9.461, CI: 80) 査読付
Satoh N, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Yoshimasa Y, Nakao K. Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci Lett. 249: 107-110, 1998 (IF: 3.046, CI: 164) 査読付
Azuma N, Yoshimasa Y, Nishimura H, Yamamoto Y, Masuzaki H, Suga J, Shigemoto M, Matsuoka N, Tanaka T, Satoh N, Igaki T, Miyamoto Y, Itoh H, Yoshimasa T, Hosoda K, Nishi S, Nakao K. The significance of the Trp64 Arg mutaion of the beta3-adrenergic receptor gene in impaired glucose tolerance, non-insulin-dependent diabetes mellitus, an insulin resistance in Japanese subjects. Metabolism. 47: 456-460, 1998 (IF: 8.697, CI: 10) 査読付
Satoh N, Ogawa Y, Katsuura G, Hayase M, Tsuji T, Imagawa K, Yoshimasa Y, Nishi S, Hosoda K, Nakao K. The arcuate nucleus as a primary site of satiety effect of leptin in rats. Neurosci Lett. 224: 149-152, 1997 (IF: 3.046, CI: 166) 査読
Satoh N, Ogawa Y, Katsuura G, Tsuji T, Masuzaki H, Hiraoka J, Okazaki T, Tamaki M, Hayase M, Yoshimasa Y, Nishi S, Hosoda K, Nakao K. Pathophysiological significance of the obese gene product, leptin, in ventromedial hypothalamus (VMH)–lesioned rats: evidence for loss of its satiety effect in VMH-lesioned rats. Endocrinology. 138: 947-954, 1997 (IF: 4.736, CI: 125) 査読付
Takaya K, Ogawa Y, Isse N, Okazaki T, Satoh N, Masuzaki H, Mori K, Tamura N, Hosoda K, Nakao K. Molecular cloning of rat leptin receptor isoform complementary DNAs-Identification of a missense mutation in Zucker fatty (falfa) rats. Biochem Biophys Res Commun. 225: 75-83, 1996 (IF: 3.575, CI: 222) 査読付
Masuzaki H, Hosoda K, Ogawa Y, Shigemoto M, Satoh N, Mori K, Tamura N, Nishi S, Yoshimasa Y, Yamori Y, Nakao K. Augmented expression of obese (ob) gene during the process of obesity in genetically obese hyperglycemic wistar fatty (falfa) rats. FEBS Lett. 378: 267-271, 1996 (IF: 4.124, CI: 38) 査読付
Isse N, Ogawa Y, Tamura N, Masuzaki H, Mori K, Okazaki T, Satoh N, Shigemoto M, Yoshimasa Y, Nishi S, Hosoda K, Imagawa J, Nakao K. Structural organization and chromosomal assignment of the human obese gene. J Biol Chem. 270: 27728-27733, 1995 (IF: 5.157, CI: 134) 査読付
Ogawa Y, Masuzaki H, Isse N, Okazaki T, Mori K, Shigemoto M, Satoh N, Tamura N, Hosoda K, Yoshimasa Y, Nakao K. Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. J Clin Invest. 96: 1647-1652, 1995 (IF: 14.808, CI: 214) 査読付
Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, Mori K, Tamura N, Hosoda K, Yoshimasa Y, Nakao K. Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes. 44: 855-858, 1995 (IF: 9.461, CI: 454) 査読付
